Developer of a nonviral gene therapy platform designed to provide ultrasound-mediated genetic medicines. The company’s platform utilizes microbubble-mediated sonoporation and proprietary acoustic technology to deliver diverse nucleic acid payloads to targeted organs, enabling patients with genetic diseases to access safe and cost-effective treatments without the size restrictions or immunogenicity associated with viral vectors.
